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Patients with peritoneal dialysis are at risk for malnutrition
and hypoalbuminemia, which are indicators of poor
outcome. Recently, it was shown that dialysis solutions
containing amino acids (AAs) and glucose improve protein
anabolism in peritoneal dialysis patients. We determined if
the same solutions could increase the fractional synthesis
rate of albumin along with whole-body protein synthesis.
Changes in the fractional albumin synthetic rate reflect acute
change in hepatic albumin synthesis. A random-order
cross-over study compared the effects of Nutrineals
(AA source) plus Physioneals (glucose) dialysate with
Physioneals alone dialysate. Eight patients in the
overnight fasting state were compared to 12 patients in
the daytime-fed state. Fractional albumin synthetic rate
and whole-body protein synthesis were determined
simultaneously using a primed-continuous infusion of
L-[1-13C]-leucine. Fractional albumin synthesis on AAs plus
glucose dialysis did not differ significantly from that on
glucose alone in the fasting or the fed state. Protein intake
by itself (fed versus fasting) failed to induce a significant
increase in the fractional synthetic rate of albumin.
Conversely, the oral protein brought about a significant
stimulation of whole-body protein synthesis. Our findings
show that the supply of AAs has different effects on
whole-body protein synthesis and the fractional synthetic
rate of albumin.
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Hypoalbuminemia has been recognized as a strong predictor
of increased risk of morbidity and mortality in peritoneal
dialysis patients.1–3 Because in protein-energy malnutrition
albumin synthesis is reduced, hypoalbuminemia traditionally
has been attributed to poor nutritional intake.4 In terms of
kinetics, plasma albumin level is determined by the synthetic
rate, the catabolic rate plus external losses, and volume of
distribution of albumin. Various clinical conditions apart
from protein-energy malnutrition affect its concentrations
including inflammatory states, volume expansion, and
increased losses of albumin.5–9 In PD patients, considerable
amounts of albumin are lost via dialysate. Plasma albumin
concentration has been found to be a poor marker of
protein-energy malnutrition.10 Most of the studies evaluating
the acute effects of nutritional intervention in patients treated
with PD, could not demonstrate appreciable alterations in the
serum albumin concentration.11
Recently, we found a stimulation of protein synthesis in
PD patients in the fasting and fed state with dialysate
containing a mixture of amino acids (AAs) plus glucose
(G).12,13 Improvements in whole-body protein synthesis by
supply of AA may be, partly, due to an increase in the
fractional synthesis rate of albumin (FSR-albumin). Altera-
tions in the FSR-albumin represent acute changes in hepatic
albumin synthesis.
In this study, we analyzed in PD patients whether
combined AA plus G dialysate could increase FSR-albumin
in PD patients both during the night in the fasting state as
well as during the day in the fed state. Moreover, by
comparing the fasting and fed state, we aimed to study the
effects of food per se. Using stable isotope infusion technique,
the FSR-albumin was measured simultaneously with the
whole-body protein synthesis (WBPS).
RESULTS
The liquid food contained on average 0.967s.d. 0.2 g
protein/kg/day and 227s.d. 5.0 kcal/kg/day, that was con-
sumed completely and was well tolerated in all patients.
In the night-time fasting and daytime-fed study, baseline
serum C-reactive protein levels ranged from 1 to 33 mg/l
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(median 9.5 mg/l) and from 1 to 40 mg/l (median 6.0 mg/l),
respectively. Baseline serum albumin was 3873.0 and
3872.0 g/l, respectively. Baseline levels of serum bicarbonate
in the fasting- and fed-state study were 22.872.2 and
23.773.3 mmol/l, respectively.
As shown in Table 1 in the night-time fasting-state study,
FSR-albumin with AA plus G dialysate was not significantly
increased as compared with G only dialysate (mean
difference: 1.07s.e. 0.7%/day, P¼ 0.18). In the daytime-fed
state study, FSR-alb was higher using AA plus G dialysate
than with G only dialysate, but again, not statistically
significant (mean difference: 0.67s.e. 0.4 %/day, P¼ 0.17).
FSR-albumin during G dialysis in the fed state was also not
significantly higher than that in the fasting state (12.07s.e.
0.5 versus 10.37s.e. 0.9%/day, respectively, mean difference
1.77s.e. 0.9, P¼ 0.07).
WBPS was significantly higher in the fed state compared
with the fasting state, both for AA plus G and G only
containing solutions (Figure 1). Baseline serum insulin in the
fasting-state study was 32.179.9 mU/l. In the fed-state study,
serum insulin levels increased significantly with either AA
plus G dialysate (22713 mU/l versus 73745 mU/l,
Po0.001) or G dialysate (18711 mU/l versus 62735 mU/l,
P¼ 0.001) when compared with baseline values. There were
no significant differences in insulin levels between the AA
plus G and G only dialysis as reported previously.13 As shown
in Table 2, plasma AA levels and in particular the essential
AAs increased significantly during AA plus G dialysis
compared with G only dialysis.
DISCUSSION
Recently, we showed an acute anabolic effect of AA plus
G-based dialysis solutions in PD patients in the fasting and
fed state.12,13 In this study, we investigated the influence of
such dialysis solutions on the FSR-albumin in PD patients.
We found that FSR-albumin values were similar to those
obtained in one previous study in Continuous Ambulatory
Peritoneal Dialysis patients.8 We did not find a statistically
significant increase in FSR-albumin with combined AA plus
G dialysate compared to G only dialysate in either the fast-
ing or in the fed state. In contrast, in several reported
experimental and human studies, it was found that albumin
synthesis increased in response to proteins or AA supple-
mentation.14,15 In a recent study in seven hemodialysis
patients, FSR-albumin increased in response to Intra Dialytic
Parenteral Nutrition.16 In this study, 11 g of AA were given
per hour of dialysis time. In our studies, about 3 g of AA per
hour of dialysis were administered. Taking into account that
about 40–50% of the supplied AA was absorbed, 1.6 g AA per
hour of dialysis was given. In our study, the failure to
demonstrate a significant effect on FSR-albumin may be due
to the low amount of AA given. However, even an oral
protein intake of 8 g per hour on average did not bring about
a statistically significant increase in FSR-albumin, as shown
when the corresponding results of the fasting- and the fed-
state study are compared. When comparing fasting and fed
state in PD patients, it is important to realize that a moderate
hyperinsulinemia is present even in fasting PD patients
through the continuous flow of glucose via dialysis
solutions.17 Various experimental and human studies provide
ample evidence that in addition to substrate availability,
insulin has a stimulating effect on hepatic albumin synth-
esis.18–20 In previously reported studies, the effects of
nutrition were assessed by comparison with a true fasting
state.14,15 This suggests that the increase in albumin synthesis
as found in those studies after a meal containing both protein
and carbohydrates could, in part be due to increased insulin
secretion. One may speculate that in our studies in fasting
PD patients, using G only dialysate, albumin synthesis was
Table 1 | Albumin kinetics
AAG dialysate G dialysate
FSR-albumin %/day FSR-albumin %/day
Fasting patients (N=8)
1 11.43 10.40
2 8.11 9.71
3 16.22 13.21
4 12.46 10.23
5 9.64 7.33
6 9.34 7.44
7 11.31 9.99
8 12.00 14.18
Mean7s.d. 11.3772.51 10.2572.53
Fed patients (N=12)
1 11.46 12.26
2 13.40 12.41
3 12.91 12.19
4 9.52 9.92
5 11.83 12.28
6 11.58 12.14
7 9.32 9.74
8 14.21 14.82
9 16.41 14.25
10 12.53 10.08
11 15.43 12.11
12 12.89 12.11
Mean7s.d. 12.6272.11 12.0371.55
AAG, amino-acid plus glucose; G, glucose; FSR, fractional synthesis rate of albumin.
P <0.001
P <0.001
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Figure 1 | Whole-body protein synthesis during fasting and fed
state. &, glucose (G) dialysate and ’, amino acid (AA) plus glucose
dialysate.
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already stimulated via insulin, so that supply of intraper-
itoneal or oral AAs did not induce a significantly further
increase of FSR-albumin.
It is certainly possible that an even higher protein intake
could have resulted in a significant increase of FSR-albumin.
Yet the effects on FSR-albumin contrast markedly with the
substantially increase in WBPS, demonstrating a differential
effect of food on the synthesis rates of albumin and whole-
body proteins. WBPS reflects the sum of protein synthesis
rates of all tissues and, in particular, of muscle and liver,
which together account for the major part of WBPS. Using
the forearm perfusion method it has been shown in PD
patients that availability of AAs promotes skeletal muscle
protein synthesis, whereas insulin has an inhibitory effect on
muscle protein breakdown.17 As muscle protein synthesis
contributes substantially to WBPS, the stimulating effect of
AAs on WBPS may be attributed to a large extent to
increased muscle protein synthesis. Protein has also been
shown to stimulate hepatic albumin synthesis. In malnutri-
tion and protein-depleted conditions in humans and animals,
albumin synthesis was found to be depressed, whereas
protein repletion resulted in a prompt recovery.21–23 In these
studies, energy intake was kept constant in the protein-
depleted and protein-replenished conditions clearly indicat-
ing that proteins and AAs modulate albumin synthesis. In
postoperative patients, intravenous administration of AAs
and energy each was found to stimulate albumin synthesis.24
In many studies, however, it is not possible to distinguish the
effects of insulin and AAs. Moreover, the comparison of
studies is complicated by marked differences in patient
characteristics, such as the presence or absence of inflam-
matory conditions,1,25 and in design including the composi-
tion and route of nutrient administration, time frame, and
measurement of albumin synthesis rate. In an animal study
for example, it was found that the stimulating effect of
insulin on albumin synthesis was blunted because of an
inhibitory effect on whole-body protein breakdown and AA
availability.26 There is some evidence that protein depletion
make albumin synthesis responsive to protein intake, which
suggests that the nutritional state may play an important role
in the effects of proteins and calories on albumin synth-
esis.25,27 On the other hand, in healthy subjects with a good
Table 2 | Plasma AAs during AAG and G dialysis in the fasting- and fed-sate studya
Overnight fasting state Daytime-fed state
AAG dialysis G dialysis AAG dialysis G dialysis
Essential
Threonine 177738** 121728 194730** 167728
Valine 240741** 125722 357772** 260 755
Methionine 1878* 978 60715** 37714
Isoleucine 85719** 56713 110724** 90721
Leucine 132723** 110723 198741** 172737
Phenylalanine 76712** 66710 113724** 93724
Lysine 174731** 155737 197727 184733
Histidine 94710** 72710 85715** 77715
Total essentialb 9957141** 7157129 13147144** 10807152
Semiessential
Tyrosine 4179 3979 96722* 89722
Cystine ND ND 14711 1177
Nonessential
Taurine 43713 45720 30712 35727
Aspartic acid ND ND 3777 31714
Asparagine 39710 3679 70713 75715
Serine 107748 76715 90718 89719
Glutamic acid 2867112 2847116 93755 90748
Glutamine 2607107 224795 475757 481764
Glycine 3827116* 3287104 254770 260766
Alanine 413795* 354793 542791* 5007107
Citrulline 105728** 90730 90727 90722
Ornithine 61713** 49715 70711** 60712
Arginine 127729** 101729 94716* 84714
Proline 290743** 240742 6227117* 5747112
Total nonessentialc 21117233** 18277239 24657243* 23697254
Total AAsd 31487344** 25817356 38907349** 35507381
AA, amino acid; AAG, amino acid and glucose; G, glucose; ND, not determined.
aData are expressed as mean7s.d. in mmol/l.
bCalculated as the sum of threonine, valine, methionine, isoleucine, leucine, phenylalanine, lysine, and histidine.
cCalculated as the sum of taurine, aspartic acid, asparagine, serine, glutamic acid, glutamine, glycine, alanine, citrulline, ornithine, arginine, and proline.
dCalculated as the sum of total essential AAs and total nonessential AAs with tyrosine (overnight fasting-state study) and with cystine and tyrosine (daytime-fed state study).
*Po0.05 versus G dialysis; **Po0.01 versus G dialysis.
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nutritional status, albumin synthesis was also found to be
stimulated after a meal.14,15 In another study in healthy
humans, albumin synthesis rates were not found to be
responsive to short-term intravenous nutrients, suggesting
that the route of administration may also play a role.28
In this study, albumin synthesis was assessed by estimation
of the FSR-albumin using stable isotope infusion technique.
With this method, enrichment of a-ketoisocaproic acid
(KIC) in plasma is measured after infusion with labeled
leucine. Other methods include determination of mRNA or
the enrichment of liver aminoacyl-tRNA, the direct precursor
of albumin synthesis.26 For these techniques and for the
determination of total liver protein synthesis as well, hepatic
tissue samples are required. Plasma KIC enrichment has been
proven to be a reliable surrogate measure of leucyl-tRNA in
liver.26 The contribution of albumin synthesis to total liver
protein synthesis is estimated at about 15%.29 Different
effects of insulin on the fractional synthesis rates of albumin
and another liver protein fibrinogen have been found in
several studies.15,18
This is the first study in PD patients to compare the effects
of supplementation of intraperitoneal AAs or food on
albumin synthesis with those on whole-body protein
metabolism. We found that the significant improvements in
WBPS were not accompanied by a parallel increase of
albumin synthesis. Such a discrepancy is consistent with the
finding that the regulation of albumin synthesis is different
from that of skeletal muscles and various other hepatic
proteins such as fibrinogen. It is worth mentioning that
plasma AAs, mainly the essential AAs, increased significantly
with both intraperitoneal and oral AA supply. It has been
reported that essential AAs, in particular, the branched
chain AAs, are responsible for the stimulation of muscle
protein anabolism by AAs.30–32 Our study was conducted
in a small, relatively stable and well-nourished population
free of liver diseases33 or acidosis,34 and without clinical
signs of inflammation. In addition, the fact that the fasting
patients were not in a true fasting state may have compli-
cated the interpretation of the results. Further work including
PD patients in a true fasting state are needed to evaluate
the effects of AA plus G containing dialysis solutions in
various clinical conditions such as inflammation and
malnutrition.
MATERIALS AND METHODS
Patients
Eight patients with end-stage renal failure undergoing Automated
Peritoneal Dialysis and 12 patients on Continuous Ambulatory
Peritoneal Dialysis were recruited from the Peritoneal Dialysis Unit
of the Erasmus Medical Center. Inclusion criteria were for stable
patients, undergoing PD for more than 3 months and who had a
weekly Kt/VX1.7. Exclusion criteria included peritonitis, other
infectious or inflammatory diseases in the previous 6 weeks,
malignant disease, and life expectancy of less than 6 months. The
local Medical Ethics Committee approved the study protocol, and
written informed consent was obtained from all study patients. The
baseline characteristics of the patients included in both studies are
summarized in Table 3.
Study design
The plasma FSR-albumin study protocol was designed as an
extension of our previous studies on the effects of peritoneal
dialysis fluids containing AA and glucose on whole-body protein
metabolism.12,13 This was an open-label, randomized, cross-over
single-center study, comparing FSR-albumin using a dialysis scheme
with dialysate containing AA plus G (Nutrineals 11% plus
Physioneals 1.36–3.86%; Baxter BV, Utrecht, The Netherlands)
and a control solution containing only G (Physioneals 1.36–3.86%).
The study was conducted both in the fasting and fed state (Figure 2),
and was performed using an automated cycler (HomeChoices,
Baxter BV) to obtain steady-state condition. Each patient was
studied on two separate days, with a 1-week interval. The patients
were randomly assigned to start with AA plus G or G dialysis.
The results of WBPS were all derived from our previously
published studies.12,13
Table 3 | Baseline characteristics of the patients in both
studiesa
Fasting-state study Fed-state study
Number of patients 8 12
Gender (M/F) 6/2 8/4
Age (year) 49.379.8 54.8712.2
Time on PD (month) 24721 15.9719.2
BMI (kg/m2) 2673.1 26.473.8
Kt/V 2.070.2 2.4170.40
nPNA (g/kg/day) 0.870.1 0.9270.24
BMI, body mass index; F, female; Kt/V, value per week; M, male; nPNA, normalized
protein equivalent of nitrogen appearance (PD adequest 2.0, software Baxter); PD,
peritoneal dialysis.
aData are mean7s.d.
13C leucine infusion
AA plus G or G dialysis
−60 0 60 120 180 240 300 360 420 480 540 min
Figure 2 | Schematic diagram of the study-day protocol of the FSR-albumin in the fed state. J denotes portions of the liquid food,
denotes time points of blood sampling.
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Dialysis procedure
In the fasting-state study, the dialysis procedure was performed in
eight patients on Automated Peritoneal Dialysis during a period of
8.5 h at night. Six exchanges either with AA plus G or G dialysate were
carried out automatically using a cycler. In the daytime, there were
one or two exchanges with G (Dianeal 1.36–3.86% or Physioneal;
Baxter BV) and/or polyglucose-containing dialysate (Extraneal,
Baxter BV). Before the study, all Automated Peritoneal Dialysis
patients used glucose-based dialysis fluid (Dianeals or Physioneals).
In the fed-state study, the dialysis procedure was carried out during
a period of 9 h at daytime. Six exchanges either with AA plus G or G
dialysate were performed automatically using a cycler to obtain
steady-state condition during the WBPT study, liquid food was given
in equal hourly aliquots. All patients used Extraneal in the night before
the study. Before the study, all patients had a dialysis scheme of four
exchanges of glucose-based dialysis fluid (Physioneals 1.36–3.86%)
during the day and a dwell of Physioneals 1.36–3.86% or Extraneal
during the night. The composition of the AA 1.1% dialysis solution
(g/l) was: histidine 0.714, isoleucine 0.850, leucine 1.020, lysine-HCl
0.955, methionine 0.850, phenylalanine 0.570, threonine 0.646,
tryptophane 0.270, valine 1.393, arginine 1.071, alanine 0.951, proline
0.595, glycine 0.510, serine 0.510, and tyrosine 0.300. The electrolyte
and buffer concentrations (mmol/l) were: Na 132, Cl 105, Ca 1.25, Mg
0.25, and lactate 40. The electrolyte and buffer composition (mmol/l)
of the 1.36, 2.27, or 3.86% G was: Na 132, Cl 95, Ca 1.25, Mg 0.25,
bicarbonate 25 mmol/l, and lactate 15 mmol/l.
Experimental procedures
FSR-albumin and WBPS were determined with a stable isotope
technique using a primed continuous intravenous infusion of
13C-leucine. Priming doses of L-[1-13C]-leucine (3.8 mmol/kg) and
of NaH13CO3 (1.7 mmol/kg) were given to label the leucine and CO2
pools, followed by a continuous infusion of L-[1-13C]-leucine
(infusion rate 0.063 mmol/kg/min). In the fasting-state study, the
8.5-h dialysis started at 2030 hours (T0). Continuous leucine
infusion was given between 0230 and 0500 hours. Blood samples
and expiratory breath samples were collected at 0230 hours
(6 h from the start of the dialysis, T360) and 30, 60, 90, 105, 120,
135, and 150 min after priming and starting the tracer infusion at
T390, T420, T450, T465, T480, T495, and T510 min. The patients were not
allowed to eat during the study. In the fed-state study, baseline blood
samples and expiratory breath samples were collected at 0800 hours
before starting the oral feeding. At 0830 hours oral feeding
consisting of 11 identical portions of a liquid complete nutritional
product (Nutridrinks Nutricia, Zoetermeer, The Netherlands) was
started and was given at regular hourly intervals to meet a steady-state
condition, except for the first three portions that were given at half
hourly intervals to induce a fed state-steady state. Other food was
not allowed. The dialysis started at 0930 hours (T0). The constant
leucine infusion was administrated during the last 3 h of the 9-h
dialysis period, started at 1530 hours and was continued for 180 min
until the end of the dialysis period at 1830 hours (T540). Blood and
expired air samples were simultaneously collected in duplicate at T420,
T450, T480, T510, T525, and T540 min, that is at 60, 90, 120, 150, 165,
and 180 min after priming and starting the tracer infusion. In both
part of the study noncaloric beverages were permitted.
Analytical procedures
The plasma-free 13C leucine enrichment was calculated from the 13C
enrichment of KIC as described previously.12,13 In brief, the 13C
enrichment was determined by gas chromatography-mass spectro-
metry by measuring the fragments 259 and 260 of the butyldi-
methylsilylquinoxalinol derivatives of natural KIC and 13C KIC,
respectively. In plasma, the measurement of 13C KIC is representa-
tive for free 13C leucine.
The enrichment of 13C leucine incorporated in albumin was
analysed as follows:
Heparinized plasma was deproteinized with TCA 20% and
centrifugated. Ethanol absolute was then added to dissolve
selectively the albumin, leaving other proteins as precipitate. After
centrifugation of this solution, the supernatant containing albumin
was dried and the residue was taken up in 0.3 mol/l NaOH at 371C.
Albumin was precipitated again from this solution with 2 mol/l
HClO4 and the pellet was hydrolysed in 6 mol/l HCL for 24 h at
1101C After drying, the hydrolysate was purified using a cation-
exchanger AG 50W-X8, 200–400 mesh, Hþ form. The AAs were
eluted with 6 mol/l ammonia and converted into the ethoxycarbo-
nyl-ethylester derivative (using ECF ethylchloroformate). The
analysis of 13C leucine enrichment in the isolated albumin took
place with gas chromatography-combustion interface-isotope ratio
mass spectrometry. The AA derivatives were converted into the GC
(Thermo Electron, Breda, The Netherlands) using PTV splitless
injection. The GC contains a CP-Sil-24 CB lowbleed/MS (Varian,
Middleburg, The Netherlands) capillary column (30 m 0.25 mm,
df¼ 0.5mm) and subsequently column FACTORfour (VF-1701MS,
30 m 0.25 mm, df¼ 1.00mm; Varian).
The AA derivatives leaving the column were combusted online at
9401C and the CO2 was online introduced into the Delta-XP IRMS
(Thermo Finnigan, Bremen, Germany). We measured at masses 44
and 45 for 12CO2 and
13CO2, respectively.
Blood chemistries
In the fasting-state study, blood samples for estimation of insulin
were taken in the fasting state before the morning exchange
before the study protocol. In the daytime study, blood samples were
collected after an overnight fast and drainage of dialysate (before
starting with oral nutrition) and at the end of the study days. Blood
samples were taken during the AA plus G and G only dialysis at the
end of the WBPT study to determine plasma AA levels, both in the
fasting- and fed-state study.
Insulin was measured by a chemiluminescent immunometric
assay (Immulite 2000 Insulin; DPC, Los Angeles, CA, USA). The
AAs were measured by ion-exchange chromatography on a
Biochrome 20 amino acid analyzer with ninhydrin detection
(Biochrome, Cambridge, UK). Other determinations were per-
formed according to routine laboratory procedures.
Calculations
WBPS was calculated from 13C KIC enrichment, 13C leucine
infusion rate and the rate of expired 13CO2, as described
previously.12,13 FSR-albumin is the fraction of the intravascular
albumin pool, expressed as percentage, synthesized per day and
was calculated as shown in the formula: FSR-albumin (%/day)¼
(13C leucinealb) (13C KICave)1 60 24 100.
13C leucinealb is expressed as mole percent excess (MPE) change
per minute of 13C leucine incorporated in albumin. The change in
albumin enrichment per min was calculated from the regression line
using data between the start and the end of the time period selected
for measurements (t¼ 390–540 min). The plasma 13C enrichment of
free leucine, represented by (13C KICave) was found by determining
the average 13C KIC enrichment from the period of measurement
and is expressed as MPE.
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MPE stands for mole percent excess of the isotopic-labeled
molecule that was measured. The other numbers convert the data
into percentage fractional synthetic rate per day.
Statistical analysis
Data were analysed using the statistical program SPSS, version 11.0,
for Windows (SPSS Inc., Chicago, IL, USA). Data are expressed as
mean7s.d., or indicated otherwise. The paired t-test was used to
compare differences between the two treatment regimens (AA plus
G versus G only dialysis) in the cross-over experiment. The unpaired
t-test was used to compare differences regarding FSR-albumin
between the fasting- and fed-state study. Differences were considered
statistically significant when the two-sided P-value was o0.05.
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